Press Releases

May 10, 2022
Quanterix reports continued revenue growth as it scales to support transformational advances in neurology research BILLERICA, Mass. --(BUSINESS WIRE)--May 10, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision
Apr 04, 2022
Company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in individual patients BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 4, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company
Mar 09, 2022
BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 9, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky will present in-person at the
Mar 01, 2022
Masoud Toloue , President of Quanterix and Diagnostics, to Become CEO and Join Board of Directors Kevin Hrusovsky , Chairman and CEO of Quanterix , to Assume Role as Executive Chairman of the Board Moves are Designed to Propel the Precision Health Vision and Catalyze the Next Chapter of Growth and
Displaying 1 - 10 of 17